Skip to main content

Advertisement

Log in

Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Purpose

To compare the diagnostic performances of contrast-enhanced digital mammography (CEDM) and breast MRI in evaluations of breast cancer, with a focus on the impact of background parenchymal enhancement (BPE) levels.

Methods

The present study included women who underwent CEDM and breast MRI to evaluate the disease extent of breast cancer between January 2018 and December 2019. Readers judged BPE levels (minimal-mild or moderate-marked) on CEDM, and were asked to assign findings suggesting malignancy using the following criteria: (1) enhancement other than BPE and (2) BI-RADS 4/5 calcifications without enhancement. On MRI, BI-RADS 3 and BI-RADS 4/5 lesions were evaluated as benign and malignant, respectively. The diagnostic performances of CEDM and MRI were compared separately between women with minimal-mild BPE and those with moderate-marked BPE.

Results

Sixty-nine patients comprising 43 postmenopausal and 26 premenopausal women were included in the present study. In total, 195 lesions (94 malignant and 101 benign) were identified. The sensitivity and specificity of CEDM for the diagnosis of all lesions were 90.8 and 91.5% with minimal-mild BPE and 79.3 and 76.2% with moderate-marked BPE, respectively. The sensitivity and specificity of MRI were 90.0% and 71.0% with minimal-mild BPE and 87.5% and 78.1% with moderate-marked BPE, respectively. The accuracy of CEDM was significantly superior to that of MRI in women with minimal-mild BPE on both CEDM and MRI (p = 0.002). Regarding the negative impact of a correct diagnosis on CEDM, the odds ratio of “moderate-marked BPE” was 0.382.

Conclusion

In patients with minimal-mild BPE, the diagnostic performance of CEDM was superior to that of MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lewin JM, Isaacs PK, Vance V, Larke FJ. Dual energy contrast enhanced digital mammography feasibility. Radiology. 2003;229:261–8. https://doi.org/10.1148/radiol.2291021276.

    Article  PubMed  Google Scholar 

  2. Cheung YC, Lin YC, Wan YL, et al. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis. Eur Radiol. 2014;24:2394–403. https://doi.org/10.1007/s00330-014-3271-1.

    Article  PubMed  Google Scholar 

  3. Mori M, Akashi-Tanaka S, Suzuki S, et al. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts. Breast Cancer. 2017;24:104–10. https://doi.org/10.1007/s12282-016-0681-8.

    Article  PubMed  Google Scholar 

  4. Sorin V, Yagil Y, Yosepovich A, et al. Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR Am J Roentgenol. 2018;211:W267–74. https://doi.org/10.2214/AJR.17.19355.

    Article  PubMed  Google Scholar 

  5. Bozzini A, Nicosia L, Pruneri G, et al. Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study. Breast Cancer Res Treat. 2020;184:723–31. https://doi.org/10.1007/s10549-020-05881-2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dromain C, Thibault F, Muller S, et al. Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol. 2010;21:565–74. https://doi.org/10.1007/s00330-010-1944-y.

    Article  PubMed  Google Scholar 

  7. Jochelson MS, Dershaw DD, Sung JS, et al. Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology. 2013;266:743–51. https://doi.org/10.1148/radiol.12121084.

    Article  PubMed  Google Scholar 

  8. Fallenberg EM, Schmitzberger FF, Amer H, et al. Contrast-enhanced spectral mammography vs. mammography and MRI: clinical performance in a multi-reader evaluation. Eur Radiol. 2017;27:2752–64. https://doi.org/10.1007/s00330-016-4650-6.

    Article  PubMed  Google Scholar 

  9. Lee-Felker SA, Tekchandani L, Thomas M, et al. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the evaluation of extent of disease. Radiology. 2017;285:389–400. https://doi.org/10.1148/radiol.2017161592.

    Article  PubMed  Google Scholar 

  10. Xiang W, Rao H, Zhou L. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer. Thorac Cancer. 2020;11:1423–32. https://doi.org/10.1111/1759-7714.13400.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ghaderi KF, Phillips J, Perry H, Lotfi P, Mehta TS. Contrast-enhanced mammography: current applications and future directions. Radiographics. 2019;39:1907–20. https://doi.org/10.1148/rg.2019190079.

    Article  PubMed  Google Scholar 

  12. Richter V, Hatterman V, Preibsch H, et al. Contrast-enhanced spectral mammography in patients with MRI contraindications. Acta Radiol. 2018;59:798–805. https://doi.org/10.1177/0284185117735561.

    Article  PubMed  Google Scholar 

  13. Perry H, Phillips J, Dialani V, et al. Contrast-enhanced mammography: a systematic guide to interpretation and reporting. AJR Am J Roentgenol. 2019;212:222–31. https://doi.org/10.2214/AJR.17.19265.

    Article  PubMed  Google Scholar 

  14. Sogani J, Morris EA, Kaplan JB, et al. Comparison of background parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging. Radiology. 2017;282:63–73. https://doi.org/10.1148/radiol.2016160284.

    Article  PubMed  Google Scholar 

  15. Zhao S, Zhang X, Zhong H, et al. Background parenchymal enhancement on contrast-enhanced spectral mammography: influence of age, breast density, menstruation status, and menstrual cycle timing. Sci Rep. 2020;10:8608. https://doi.org/10.1038/s41598-020-65526-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. American College of Radiology. ACR BI-RADS® Mammography. In: ACR BI-RADS Atlas. 5th ed. Reston: American College of Radiology; 2013.

  17. American College of Radiology. ACR BI-RADS® MRI. In: ACR BI-RADS Atlas. 5th ed. Reston: American College of Radiology; 2013.

  18. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet. 2010;375:563–71. https://doi.org/10.1016/S0140-6736(09)62070-5.

    Article  PubMed  Google Scholar 

  19. Miller BT, Abbott AM, Tuttle TM. The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol. 2012;19:536–40. https://doi.org/10.1245/s10434-011-1932-8.

    Article  PubMed  Google Scholar 

  20. Covington MF, Pizzitola VJ, Lorans R, et al. The future of contrast-enhanced mammography. AJR Am J Roentogenol. 2018;210:292–300. https://doi.org/10.2214/AJR.17.18749.

    Article  Google Scholar 

  21. Bhimani C, Matta D, Roth RG, et al. Contrast-enhanced spectral mammography: technique, indications, and clinical applications. Acad Radiol. 2017;24:84–8. https://doi.org/10.1016/j.acra.2016.08.019.

    Article  PubMed  Google Scholar 

  22. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium dependency. Radiology. 1997;203:137–44. https://doi.org/10.1148/radiology.203.1.9122382.

    Article  CAS  PubMed  Google Scholar 

  23. Müller-Schimpfle M, Ohmenhaüser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145–9. https://doi.org/10.1148/radiology.203.1.9122383.

    Article  PubMed  Google Scholar 

  24. Scaranelo AM, Carrillo MC, Fleming R, et al. Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density. Radiology. 2013;267:692–700. https://doi.org/10.1148/radiol.13120121.

    Article  PubMed  Google Scholar 

  25. Zanardo M, Cozzi A, Trimboli RM, et al. Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review. Insight Imaging. 2019;10:76. https://doi.org/10.1186/s13244-019-0756-0.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by a research grant from FUJIFILM Corporation (Tokyo, Japan). The statistical analysis was conducted by Cimic Co., Ltd. We greatly appreciate all medical staff and clinical research coordinators in this clinical study for their contributions.

Funding

This study was supported by a research grant from FUJIFILM Corporation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sachiko Yuen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This retrospective study was approved by the Certified Review Board of the Japan Registry of Clinical Trials (jRCTs052180121) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standard.

Informed consent

Written informed consent to participate in the present study after a full explanation by the clinical research coordinator was obtained from all patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuen, S., Monzawa, S., Gose, A. et al. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI. Breast Cancer 29, 677–687 (2022). https://doi.org/10.1007/s12282-022-01345-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-022-01345-1

Keywords

Navigation